Business Context and Reporting Period
This Form 8-K is a current report filed by Anthem, Inc. (now Elevance Health, Inc.) on May 18, 2017. The filing documents the results of the Company's Annual Meeting of Shareholders held on the same date, covering corporate governance matters, director elections, and shareholder approvals of specific plans and amendments.
Financial Metrics
This filing is a corporate governance report and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing reports the following material corporate actions approved by shareholders on May 18, 2017:
- Articles of Incorporation Amendment: Shareholders approved amendments granting them the ability to amend the Company's By-Laws, subject to restrictions related to the Blue Cross and Blue Shield Association license agreement.
- By-Laws Amendment: The Board amended the By-Laws to align with the Articles of Incorporation and removed all references to the Executive Committee, which has been disbanded.
- Compensation Plan Approval: Shareholders approved the 2017 Anthem Incentive Compensation Plan.
Shareholder Votes and Governance
The following matters were submitted to a vote of security holders with the results detailed below:
- Election of Directors: All nominees (R. Kerry Clark and Robert L. Dixon, Jr.) were elected to three-year terms expiring in 2020. Significant broker non-votes were recorded for these items.
- Ratification of Auditors: The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2017 was ratified.
- Executive Compensation (Say-on-Pay): Shareholders approved the advisory vote on executive compensation, though a notable portion of votes were cast against the proposal.
- Frequency of Say-on-Pay Votes: The majority of shareholders voted for an annual ("1 Year") frequency for future advisory votes on executive compensation. The Board determined to hold these votes annually.
Key Facts for Investor Verification
- Verify the specific terms of the 2017 Anthem Incentive Compensation Plan filed as Exhibit 10.1 to understand potential dilution or payout structures.
- Review the Amended and Restated Articles of Incorporation (Exhibit 3.1) to confirm the scope of shareholder rights regarding By-Law amendments.
- Note the disbanding of the Executive Committee as reflected in the amended By-Laws (Exhibit 3.2).
- Observe the voting dissent on the executive compensation advisory vote (approximately 12.5 million votes against) and the frequency vote (approximately 25.5 million votes for a 3-year frequency), which may indicate shareholder sentiment regarding governance.